DMARD is a term that is used interchangeably with second-line medications, slow-acting antirheumatic drugs, or disease-controlling antirheumatic therapy. The
by SS Zhao 2024 Cited by 17rheumatoid arthritis; antirheumatic drugs, disease-modifying; antirheumatic agents; biological products; rheumatology; treatment outcome
antirheumatic drugs (csDMARDs). The most commonly used csDMARDs in antirheumatic drug, ILD interstitial lung disease, IVIg
Pages in category Disease-modifying antirheumatic drugs ; Disease-modifying antirheumatic drug ; A. Abatacept Adalimumab Anakinra Apremilast Auranofin
Disease-Modifying Antirheumat Drugs Misc, Disease-Modifying Antirheumatic Bile And Liver Therapy, Bile Therapy, Bimatoprost, Bimekizumab, Bisacodyl
disease-modifying antirheumatic drugs (DMARDs) in PsA. Methods. Literature search DMARD, disease-modifying antirheumatic drug; LEF, leflunomide; MTX
These compounds, called disease-modifying antirheumatic drugs (DMARDs) or slow-acting antirheumatic drugs (SAARDs), currently include MTX, the antimalarials
These compounds, called disease-modifying antirheumatic drugs (DMARDs) or slow-acting antirheumatic drugs (SAARDs), currently include MTX, the antimalarials
NSAIDs in combination with paracetamol are classified in N02BE. Disease Modifying Antirheumatic Drugs (DMARDs) see: Other Disease Modifying Antirheumatic
Comments